Astec Lifesciences: September ’22 Results Update
Moneylife Digital Team 23 November 2022
In Q2FY22-23, Astec Lifesciences (Astec) nearly doubled its sales y-o-y (year-on-year) to Rs200 crore. The robust top-line performance was driven by higher sales realisation and volumes in exports...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback